T. Rowe Price Associates’s Assembly Biosciences ASMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$259K Buy
11,022
+2,819
+34% +$80.6K ﹤0.01% 2911
2026
Q2
$226K Buy
+8,203
New +$223K ﹤0.01% 2966
2020
Q4
– Sell
-51,520
Closed -$10.2M – 2667
2020
Q3
$10.2M Sell
51,520
-5,241
-9% -$1.32M ﹤0.01% 1298
2020
Q2
$15.9M Sell
56,761
-4,665
-8% -$1.09M ﹤0.01% 1200
2020
Q1
$10.9M Sell
61,426
-12,548
-17% -$2.69M ﹤0.01% 1217
2019
Q4
$18.2M Buy
+73,974
New +$13.6M ﹤0.01% 1214
2018
Q4
– Sell
-18,525
Closed -$8.26M – 2562
2018
Q3
$8.26M Buy
18,525
+1,034
+6% +$484K ﹤0.01% 1404
2018
Q2
$8.23M Buy
17,491
+2,535
+17% +$1.34M ﹤0.01% 1377
2018
Q1
$8.82M Buy
+14,956
New +$9.27M ﹤0.01% 1360

Other funds holding ASMB

T. Rowe Price Associates's ASMB Position: Q3 2026 in Review

T. Rowe Price Associates increased its Assembly Biosciences (ASMB) stake by 34% in Q3 2026, buying an estimated $80.6K and bringing the position to 11,022 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #2911.

T. Rowe Price Associates first reported a position in ASMB in Q1 2018 and has held it in 9 quarters since. The position peaked at $18.2M in Q4 2019. 104 funds tracked by Wall St. Rank hold ASMB as of Q3 2026.

  • T. Rowe Price Associates held 11,022 shares of Assembly Biosciences worth $259K as of Q3 2026.
  • T. Rowe Price Associates bought 2,819 Assembly Biosciences shares in Q3 2026, an estimated $80.6K.
  • Assembly Biosciences made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q3 2026, its #2911 holding.
  • T. Rowe Price Associates first reported a position in Assembly Biosciences in Q1 2018 and has held it in 9 quarters since.
  • T. Rowe Price Associates's Assembly Biosciences position peaked at $18.2M in Q4 2019.
  • 104 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2026.

Based on T. Rowe Price Associates's 13F filing for Q3 2026, filed 16 Nov 2026.